1. Home
  2. BCYC vs TMCI Comparison

BCYC vs TMCI Comparison

Compare BCYC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.21

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$4.65

Market Cap

279.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCYC
TMCI
Founded
2009
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.8M
279.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BCYC
TMCI
Price
$4.21
$4.65
Analyst Decision
Buy
Hold
Analyst Count
10
6
Target Price
$13.90
$4.77
AVG Volume (30 Days)
286.7K
392.8K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$212,690,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.59
52 Week Low
$3.75
$1.17
52 Week High
$9.16
$7.46

Technical Indicators

Market Signals
Indicator
BCYC
TMCI
Relative Strength Index (RSI) 58.92 52.26
Support Level $4.25 $3.84
Resistance Level $4.51 $4.67
Average True Range (ATR) 0.14 0.27
MACD 0.04 -0.01
Stochastic Oscillator 71.09 43.42

Price Performance

Historical Comparison
BCYC
TMCI

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Share on Social Networks: